- Home
- RMT vs AUTL Comparison
RMT vs AUTL Comparison
Compare RMT & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMT | AUTL |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 460.2M | 368.6M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | RMT | AUTL |
|---|---|---|
| Price | $10.60 | $1.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.33 |
| AVG Volume (30 Days) | 111.5K | ★ 3.8M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 7.37% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.49 | N/A |
| Revenue | N/A | ★ $51,128,000.00 |
| Revenue This Year | N/A | $658.11 |
| Revenue Next Year | N/A | $91.34 |
| P/E Ratio | $6.18 | ★ N/A |
| Revenue Growth | N/A | ★ 406.67 |
| 52 Week Low | $7.67 | $1.11 |
| 52 Week High | $9.51 | $2.88 |
Technical Indicators
Market Signals| Indicator | RMT | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 57.10 | 59.11 |
| Support Level | $10.53 | $1.46 |
| Resistance Level | $10.94 | $1.66 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 69.03 | 84.04 |
Price Performance
Historical ComparisonAbout RMT Royce Micro-Cap Trust Inc.
Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparels, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.